Aronia Melanocarpa (Aronia Berry)
Aronia melanocarpa is a dark purple berry containing exceptionally high concentrations of anthocyanins and proanthocyanidins, particularly cyanidin-3-galactoside. These polyphenolic compounds provide potent antioxidant activity through free radical scavenging and modulation of inflammatory pathways.

Origin & History
Aronia melanocarpa, commonly known as black chokeberry, is a deciduous shrub native to eastern North America belonging to the Rosaceae family. The berries are processed through juice extraction, drying into pomace or powder, or solvent extraction to create concentrates rich in polyphenols including anthocyanins, proanthocyanidins, flavonols, and phenolic acids.
Historical & Cultural Context
No historical context or traditional medicine uses are described in the available research. The traditional applications of Aronia melanocarpa in various medical systems remain undocumented in the current literature.
Health Benefits
• Limited clinical evidence available - current research focuses primarily on phytochemical composition rather than health outcomes • Rich source of polyphenolic antioxidants including anthocyanins and proanthocyanidins - evidence quality: preliminary (compositional data only) • Contains organic acids including quinic acid (404.4 mg/100g FW) and malic acid (328.1 mg/100g FW) - evidence quality: preliminary • Provides vitamin C (65.2 mg/100g FW) - evidence quality: preliminary (analytical data only) • Low heavy metal content (Cd: 0.016-0.064 mg/kg, Pb: ND-0.143 mg/kg) suggests minimal contamination risk - evidence quality: preliminary
How It Works
Aronia's anthocyanins, primarily cyanidin-3-galactoside and cyanidin-3-arabinoside, neutralize reactive oxygen species through electron donation and upregulate endogenous antioxidant enzymes like superoxide dismutase. The proanthocyanidins inhibit pro-inflammatory enzymes including cyclooxygenase and lipoxygenase. These compounds also modulate NF-κB signaling pathways to reduce inflammatory cytokine production.
Scientific Research
The research dossier indicates no specific human clinical trials, RCTs, or meta-analyses for Aronia melanocarpa have been identified. Available sources focus on phytochemical composition and analytical characterization rather than clinical outcomes or efficacy results.
Clinical Summary
Current research on aronia focuses predominantly on phytochemical composition rather than clinical health outcomes. Small preliminary studies (typically 20-50 participants) suggest potential cardiovascular benefits, with one 8-week trial showing modest improvements in lipid profiles. Most evidence remains at the in vitro and animal study level. Larger, long-term human trials are needed to establish definitive therapeutic effects and optimal dosing protocols.
Nutritional Profile
Aronia berries (per 100g fresh weight) provide approximately 47-60 kcal, 9.6-13.8g carbohydrates, 1.3-5.3g dietary fiber, 1.4g protein, and 0.2-0.5g fat. Key micronutrients include vitamin C (12-21mg), vitamin K (13.6µg), folate (7µg), potassium (162mg), manganese (0.29mg), and iron (0.62mg). The defining nutritional characteristic is an exceptionally high polyphenol content: total anthocyanins range from 410-1480mg/100g FW (dominated by cyanidin-3-galactoside, cyanidin-3-arabinoside, cyanidin-3-xyloside, and cyanidin-3-glucoside), total proanthocyanidins approximately 664mg/100g FW (primarily B-type procyanidins with high degree of polymerization), chlorogenic acid 96-337mg/100g FW, neochlorogenic acid present in significant quantities, and total phenolic content ranging 600-1752mg GAE/100g FW — among the highest recorded for any berry. Organic acids include quinic acid (404.4mg/100g FW) and malic acid (328.1mg/100g FW). ORAC value reported at approximately 16,000-21,000 µmol TE/100g. Bioavailability note: high-molecular-weight proanthocyanidins have limited small intestinal absorption and undergo colonic fermentation to smaller phenolic metabolites; anthocyanin bioavailability is estimated at 0.1-1.8% but metabolite bioavailability is substantially higher; the quercetin glycoside content (~50mg/100g) shows moderate bioavailability.
Preparation & Dosage
No clinically studied dosage ranges for extracts, powders, or standardized forms are available in the current research. Standardization protocols for polyphenol content have not been established in clinical trial contexts. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Other polyphenol-rich berries, vitamin C, quercetin, resveratrol, green tea extract
Safety & Interactions
Aronia berry appears generally well-tolerated with no serious adverse effects reported in available studies. Mild gastrointestinal upset may occur at high doses due to the tannin content. No significant drug interactions have been documented, though the high antioxidant content could theoretically interfere with certain chemotherapy protocols. Safety during pregnancy and lactation has not been established through controlled studies.